Remove 2008 Remove Documentation Remove Dosage
article thumbnail

CMC Requirements for New Drug Registration in Latin America

ISPE

Improvements have been observed by various regulatory agencies in Latin America for the acceptance and implementation of international standards—for instance, the ICH Common Technical Document (CTD) format. Additional required information beyond ICH guidelines, or non-value-added documents (e.g., 6, and 2.3.S.7 7 are required.

article thumbnail

A Proposal for a Comprehensive Quality Overall Summary

ISPE

Concept Paper: M4Q(R2) Common Technical Document on Quality Guideline.” Published June 2008. If elements such as these are adopted during the revision of ICH M4Q, this could influence global regulatory agencies to eliminate the requirement for custom Module 2 commitment documents. The authors propose using Module 2.3

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

A Proposal for a Comprehensive Quality Overall Summary

ISPE

Concept Paper: M4Q(R2) Common Technical Document on Quality Guideline.” Published June 2008. If elements such as these are adopted during the revision of ICH M4Q, this could influence global regulatory agencies to eliminate the requirement for custom Module 2 commitment documents. The authors propose using Module 2.3

article thumbnail

Escitalopram interactions to avoid

The Checkup by Singlecare

Carefully read these documents as they contain important safety information, including information about interactions. Some interactions require the dosages of the medications to be adjusted, while other interactions mean the two drugs should not be taken together at all.

article thumbnail

A Systemwide Approach to Managing the Risks of Continuous Manufacturing

ISPE

For much of the pharmaceutical industry, batch manufacturing (BM) processes that have been relied upon for decades remain the preferred approach for most oral solid dosage (OSD) drug products. This document catalogs and summarizes the various risks to the company. A companion to the risk appetite statement is the risk taxonomy.

article thumbnail

Regulatory Landscape for Raw Materials: CMC Considerations

ISPE

The Common Technical Document (CTD) for the Registration of Pharmaceuticals For Human Use: Quality—M4Q guidance covers the minimum requirements for submission of raw materials; however, certain regions have additional requirements. The absence of any of the listed documentation should be scientifically justified.

article thumbnail

Enabling Global Pharma Innovation: Delivering for Patients

ISPE

Published June 2008. en/documents/other/european-medicines-agencies-network-strategy-2025-protecting-public-health-time-rapid-change_en.pdf 11 European Medicines Agency. link] 5 International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use. 22 June 2023. EMA/321483/2020. 3 July 2020.

FDA 52